Holen Sie sich die Stockscreener-App
8.01
1.23%
-0.10
Handel nachbörslich:
8.01
Schlusskurs vom Vortag:
$8.11
Offen:
$7.96
24-Stunden-Volumen:
2.37M
Relative Volume:
0.88
Marktkapitalisierung:
$891.19M
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-6.0226
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
+3.09%
1M Leistung:
+3.22%
6M Leistung:
+430.46%
1J Leistung:
+55.53%
1-Tages-Spanne:
$7.74
$8.14
1-Wochen-Bereich:
$7.57
$8.35
52-Wochen-Spanne:
$1.03
$9.70
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
8.01 | 1.07B | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Can Tango Therapeutics Inc. stock outperform in 2025 bull market2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Does Tango Therapeutics Inc. fit your quant trading modelAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Is Tango Therapeutics Inc. stock entering bullish territory2025 Dividend Review & Safe Capital Investment Plans - newser.com
Will Tango Therapeutics Inc. stock attract ESG investorsJuly 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com
Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: W - GuruFocus
Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Why Tango Therapeutics Inc. is moving todayQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Long term hold vs stop loss in Tango Therapeutics Inc.Swing Trade & Accurate Intraday Trading Signals - newser.com
How Tango Therapeutics Inc. stock performs in rising dollar environmentTrade Volume Report & Short-Term High Return Ideas - newser.com
Why Tango Therapeutics Inc. stock is trending among retail tradersPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com
Short interest data insights for Tango Therapeutics Inc.Treasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
Ranking Tango Therapeutics Inc. among high performing stocks via toolsWeekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Tango Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - sharewise.com
Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today - AOL.com
What is HC Wainwright's Estimate for TNGX FY2026 Earnings? - MarketBeat
How to build a dashboard for Tango Therapeutics Inc. stock2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Will Tango Therapeutics Inc. stock maintain dividend yield2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Multi asset correlation models including Tango Therapeutics Inc.Market Growth Review & High Conviction Investment Ideas - newser.com
Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? - Mitrade
Tango Therapeutics price target raised to $12 from $10 at Guggenheim - MSN
Tango Therapeutics’ Promising Update on TNG260 Clinical Study - MSN
TNGX FY2025 EPS Forecast Boosted by Cantor Fitzgerald - MarketBeat
Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study - MSN
Tango Therapeutics (TNGX) Expected to Announce Earnings on Wednesday - MarketBeat
Tango Therapeutics Inc. (TNGX) Stock Price | Live Quotes & Charts | NSD - StocksToTrade
Tango Therapeutics Advances Innovative Cancer Treatment with S095035 Clinical Trial - TipRanks
Why Tango Therapeutics (TNGX) Surged After Positive Vopimetostat Trial Results and Major Capital Raise - Yahoo Finance
Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - The Manila Times
Tango (NASDAQ: TNGX) will report third quarter results Nov 4; no conference call - Stock Titan
Tango Therapeutics (TNGX) Price Target Increased by 11.49% to 12.37 - Nasdaq
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Major Shareholder Sells 477,401 Shares of Stock - MarketBeat
Tango Therapeutics Stock Fell 15% in a Week, What Now? - Trefis
Will Tango Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Spike Watch & Free Verified High Yield Trade Plans - fcp.pa.gov.br
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):